ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 127 filers reported holding ANI PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 3.85 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $248 | -99.9% | 4,280 | -20.9% | 0.02% | -10.7% |
Q4 2021 | $250,000 | +3.3% | 5,410 | +30.2% | 0.03% | -22.2% |
Q1 2018 | $242,000 | -49.5% | 4,155 | -44.2% | 0.04% | -57.6% |
Q4 2017 | $479,000 | +128.1% | 7,442 | +65.9% | 0.08% | +112.5% |
Q2 2017 | $210,000 | – | 4,485 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Mesirow Financial Investment Management, Inc. | 9,433 | $266,000 | 1.14% |
Global Alpha Capital Management Ltd. | 258,946 | $7,305,000 | 1.12% |
Birch Grove Capital LP | 50,791 | $1,433,000 | 0.78% |
1492 Capital Management LLC | 25,003 | $705,000 | 0.53% |
INVESTMENT COUNSELORS OF MARYLAND LLC | 321,975 | $9,083,000 | 0.41% |
THB ASSET MANAGEMENT | 48,385 | $1,364,000 | 0.38% |
Regent Investment Management LLC | 36,979 | $1,043,000 | 0.32% |
GLOBEFLEX CAPITAL L P | 41,212 | $1,163,000 | 0.31% |
HUSSMAN STRATEGIC ADVISORS, INC. | 35,500 | $1,001,000 | 0.26% |
Ranger Investment Management | 124,763 | $3,520,000 | 0.22% |